Pharmagreen Biotech Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Pharmagreen Biotech Inc. reported Cash And Cash Equivalents At Carrying Value of $25.3 thousand for the year ending 2021.

  • Pharmagreen Biotech Inc. showed an increase of +107.4% in Cash And Cash Equivalents At Carrying Value from 2020 to 2021.
  • This data is from Pharmagreen Biotech Inc.'s annual report (Form 10-K), filed with the SEC on December 29, 2021.
  • XBRL data for this metric is available from 2019 to 2021 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2019 to 2021), Pharmagreen Biotech Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 59.6%.
  • Historical annual values: Fiscal year 2021: $25.3 thousand | Fiscal year 2020: $12.2 thousand | Fiscal year 2019: $62.7 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: